Remimazolam: Is the Sedative of the Future Here? https://pubs.asahq.org/monitor/article/84/10/1/110709/Remimazolam-Is-the-Sedative-of-the-Future-Here link Dr. Sorooshian: We believe BYFAVO will become a key component in sedation and anesthesia practice. The encouraging safety profile of BYFAVO, even in patients with ASA Physical Status scores of III and IV, should make it appropriate in a wide variety of settings and patient populations.